Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism
Authors
Keywords
Smac/DIABLO, Inhibitor of apoptosis protein (IAP), TRAIL, Inflammatory breast cancer (IBC), TNF- α
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 137, Issue 2, Pages 359-371
Publisher
Springer Nature
Online
2012-12-06
DOI
10.1007/s10549-012-2352-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Requirement of Nuclear Factor κB for Smac Mimetic–Mediated Sensitization of Pancreatic Carcinoma Cells for Gemcitabine-Induced Apoptosis
- (2015) Dominic Stadel et al. NEOPLASIA
- Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells
- (2012) Bisrat G. Debeb et al. BREAST CANCER RESEARCH AND TREATMENT
- Proinflammatory Characteristics of SMAC/DIABLO-Induced Cell Death in Antitumor Therapy
- (2012) P. U. Emeagi et al. CANCER RESEARCH
- Smac Mimetic LBW242 Sensitizes XIAP-Overexpressing Neuroblastoma Cells for TNF- -Independent Apoptosis
- (2012) G. Eschenburg et al. CANCER RESEARCH
- Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL
- (2012) Goodwin Jinesh G. et al. JOURNAL OF LEUKOCYTE BIOLOGY
- XIAP Inhibition and Generation of Reactive Oxygen Species Enhances TRAIL Sensitivity in Inflammatory Breast Cancer Cells
- (2012) J. L. Allensworth et al. MOLECULAR CANCER THERAPEUTICS
- Targeting IAP proteins for therapeutic intervention in cancer
- (2012) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner
- (2012) L Wagner et al. ONCOGENE
- ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells
- (2011) Katherine M. Aird et al. BREAST CANCER RESEARCH AND TREATMENT
- In mouse embryonic fibroblasts, neither caspase-8 nor cellular FLICE-inhibitory protein (FLIP) is necessary for TNF to activate NF-κB, but caspase-8 is required for TNF to cause cell death and induction of FLIP by NF-κB is required to prevent it
- (2011) D M Moujalled et al. CELL DEATH AND DIFFERENTIATION
- Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patients
- (2011) P. PLUTA et al. NEOPLASMA
- Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer
- (2010) Takayuki Iwamoto et al. BREAST CANCER RESEARCH AND TREATMENT
- Inflammatory Breast Cancer: The Disease, the Biology, the Treatment
- (2010) Fredika M. Robertson et al. CA-A CANCER JOURNAL FOR CLINICIANS
- X-linked Inhibitor of Apoptosis: A Chemoresistance Factor or a Hollow Promise
- (2010) H. Kashkar CLINICAL CANCER RESEARCH
- Prognostic value of the X-linked inhibitor of apoptosis protein for invasive ductal breast cancer with triple-negative phenotype
- (2010) Jinjing Wang et al. HUMAN PATHOLOGY
- X-Linked Inhibitor of Apoptosis Protein Inhibits Apoptosis in Inflammatory Breast Cancer Cells with Acquired Resistance to an ErbB1/2 Tyrosine Kinase Inhibitor
- (2010) K. M. Aird et al. MOLECULAR CANCER THERAPEUTICS
- XIAP impairs Smac release from the mitochondria during apoptosis
- (2010) L Flanagan et al. Cell Death & Disease
- Attenuating Smac mimetic compound 3-induced NF-κB activation by luteolin leads to synergistic cytotoxicity in cancer cells
- (2009) Lang Bai et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer
- (2009) Deborah Silvera et al. NATURE CELL BIOLOGY
- TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype
- (2008) Monzur Rahman et al. BREAST CANCER RESEARCH AND TREATMENT
- SM-164: A Novel, Bivalent Smac Mimetic That Induces Apoptosis and Tumor Regression by Concurrent Removal of the Blockade of cIAP-1/2 and XIAP
- (2008) J. Lu et al. CANCER RESEARCH
- Acquired Resistance to Small Molecule ErbB2 Tyrosine Kinase Inhibitors
- (2008) F. L. Chen et al. CLINICAL CANCER RESEARCH
- Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression
- (2008) K. M. Aird et al. MOLECULAR CANCER THERAPEUTICS
- cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination
- (2008) Mathieu J.M. Bertrand et al. MOLECULAR CELL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started